Swedish Orphan Biovitrum, Strada Quarta 6/1 D – 43123 Parma (PR)
(from 01/04/2013 to 30/06/2014 = 1 year and 3 months)
In the TAs (Therapeutic Areas) «inflammation/rheumatology»:
- preparation of the Italian pricing-dossier for the new, EMA-approved orphan indication of the Interleukin-1 receptor antagonist (IL-1Ra) KINERET® (anakinra), concerning the treatment of CAPS (Cryopyrin-Associated Periodic Syndrome), a rare autoinflammatory disorder
- support of Investigator Sponsored Trials (ISS) in accordance with Italian D.M. 17/12/2004 (AIR-TRIP, TRACK)
- development and continuous updating with the latest scientific publications of a literature database compatible with Mendeley®, Papership® and Endnote® citation managers
- organization of HSMs (Hospital Staff Meetings) = in-hospital scientific meetings with health care professionals (HCPs)
- management of MQs (Medical Queries) = requests for information from health care professionals (HCPs)
- collaboration with international task-forces
- marketing support for product strategy
- scientific support & training commercial field force
